Literature DB >> 3111565

Lymphocyte subpopulations in peripheral blood and bone marrow in patients with idiopathic myelofibrosis.

E Vellenga, S Poppema, C G Kallenberg, M R Halie.   

Abstract

In 8 patients with idiopathic myelofibrosis (IM) T and B cells were studied in view of the possibility that immunological dysfunctions are involved in initiating or contributing to the bone marrow fibrosis. In peripheral blood the absolute numbers of E-SRBC and OKT3+ lymphocytes were significantly reduced; in addition a significant decline was observed in the proportion and absolute numbers of OKT8+ cells, resulting in a reversed Leu-3a/OKT8 ratio. An impaired B cell function was observed in 4 of the 8 patients, characterized by a disturbed in vitro pokeweed mitogen stimulated immunoglobulin synthesis and low serum immunoglobulin levels. Immuno-histological studies of the bone marrow demonstrated a scarcity of T cells but normal numbers of B cells. However, no correlation was noted between the observed deviations of B and T cells and the degree of bone marrow fibrosis determined by means of bone marrow histology and serum procollagen-III levels. These data are not sufficient to support the hypothesis that immunological changes in IM are primarily involved in the process of bone marrow fibrosis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3111565     DOI: 10.1007/bf00631780

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  14 in total

1.  Lymphocyte-mediated activation of fibroblast proliferation and collagen production.

Authors:  S M Wahl; L M Wahl; J B McCarthy
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

2.  Immunologic enhancement of collagen accumulation in progressive systemic sclerosis (PSS).

Authors:  M K Cathcart; R S Krakauer
Journal:  Clin Immunol Immunopathol       Date:  1981-10

3.  Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts.

Authors:  H Castro-Malaspina; E M Rabellino; A Yen; R L Nachman; M A Moore
Journal:  Blood       Date:  1981-04       Impact factor: 22.113

4.  Clonal karyotype abnormalities in erythroid and granulocyte-monocyte precursors in polycythaemia vera and myelofibrosis.

Authors:  T Ruutu; S Partanen; S Knuutila
Journal:  Scand J Haematol       Date:  1983-09

5.  Immunologic abnormalities in myelofibrosis with activation of the complement system.

Authors:  B R Gordon; M Coleman; P Kohen; N K Day
Journal:  Blood       Date:  1981-11       Impact factor: 22.113

6.  Idiopathic myelofibrosis: a possible role for immune-complexes in the pathogenesis of bone marrow fibrosis.

Authors:  F C Cappio; R Vigliani; A Novarino; G Camussi; D Campana; F Gavosto
Journal:  Br J Haematol       Date:  1981-09       Impact factor: 6.998

7.  B cell activity in systemic lupus erythematosus: depressed in vivo humoral immune response to a primary antigen (haemocyanin) and increased in vitro spontaneous immunoglobulin synthesis.

Authors:  C G Kallenberg; P C Limburg; C Van Slochteren; F J Van der Woude; T H The
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

8.  Increased serum procollagen III aminoterminal peptide in myelofibrosis.

Authors:  S Hochweiss; S Fruchtman; E G Hahn; H Gilbert; P B Donovan; J Johnson; J D Goldberg; P D Berk
Journal:  Am J Hematol       Date:  1983-12       Impact factor: 10.047

9.  The significance of the aminoterminal propeptide of type III procollagen in paroxysmal nocturnal haemoglobinuria and myelofibrosis.

Authors:  E Vellenga; N H Mulder; A K van Zanten; H O Nieweg; M G Woldring
Journal:  Eur J Nucl Med       Date:  1983

10.  In situ analysis of the mononuclear cell infiltrate in primary malignant melanoma of the skin.

Authors:  S Poppema; E B Bröcker; L de Leij; D Terbrack; T Visscher; A Ter Haar; E Macher; T H Thé; C Sorg
Journal:  Clin Exp Immunol       Date:  1983-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.